An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: Synthesis and photoactivation studies

A new anticancer agent based on the conjugation of a photoactivatable Pt(iv) pro-drug to a cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was induced preferentially in SK-MEL-28 melanoma cancer cells overexpressing α<inf>V</inf>β<inf>3<...

Descripción completa

Detalles Bibliográficos
Autores: Gandioso, Albert, Shaili, Evyenia, Massaguer i Vall-llovera, Anna, Artigas, Gerard, González-Cantó, Alejandro, Woods, Julie A., Sadler, Evyenia, Marchán, Vicente
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10256/12279
Acceso en línea:http://hdl.handle.net/10256/12279
Access Level:acceso abierto
Palabra clave:Medicaments antineoplàstics
Antineoplastic agents
Descripción
Sumario:A new anticancer agent based on the conjugation of a photoactivatable Pt(iv) pro-drug to a cyclic RGD-containing peptide is described. Upon visible light irradiation, phototoxicity was induced preferentially in SK-MEL-28 melanoma cancer cells overexpressing α<inf>V</inf>β<inf>3</inf> integrin compared to control DU-145 human prostate carcinoma cells

Similares en LA Referencia